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  Johne's  disease  is  a  condition  that  refers  to  chronic 
granulomatous enteritis in ruminants. It is believed that 
survival  and  replication  of  Mycobacterium  (M.)  para-
tuberculosis  in  mononuclear  phagocytes  plays  an 
important  role  in  the  pathogenesis  of  Johne's  disease. 
However, it is not clear how M. paratuberculosis survives 
for long time periods in mononuclear phagocytes, nor is it 
clear which factors trigger multiplication of these bacilli 
and  result  in  the  development  of  Johne's  disease. 
Investigating the intracellular fate of M. paratuberculosis 
is challenging because of its very slow growth (more than 
two months to form visible colonies on media). Existing 
animal  models  also  have  limitations.  Despite  those 
o b s t a c l e s ,  t h e r e  h a s  b e e n  p r o g r e s s  i n  u n d e r s t a n d i n g  t h e  
intracellular survival tactics of M. paratuberculosis and the 
host response against them. In this review, we compare 
known aspects of the intracellular survival tactics of M. 
paratuberculosis with those of other mycobacterial species, 
and  consider  possible  mycobactericidal  mechanisms  of 
mononuclear phagocytes.    
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Introduction 
  Mycobacterium (M.) paratuberculosis is the etiologic 
agent of chronic enteritis of ruminants, known as paratu-
berculosis or Johne's disease [14]. M. paratuberculosis is a 
Gram-positive, acid-fast bacillus that belongs to the M. 
avium complex [10]. It grows very slowly and requires my-
cobactin J, an iron-chelating cell wall component produced 
by most other mycobacteria, for growth in vitro. As a re-
sult, visible colony formation takes 8 to 12 weeks or longer. 
Identification of M. paratuberculosis depends on myco-
bactin-dependent growth and detection of the spe-
cies-specific IS 900 insertion sequence by polymerase 
chain reaction (PCR) [20]. Like other mycobacteria, the 
cell wall of M. paratuberculosis is lipid-rich and consists 
of several layers. The main components of the cell wall are 
lipoarabinomannan (LAM) and arabinomannan (AM) 
[90]. It has been reported that LAM is highly immunogenic 
and reacts with sera from infected cattle [47,89]. Several 
proteins that induce a humoral immune response in infected 
cows are produced by M. paratuberculosis. These include 
17 KDa, 34 KDa, and 400 KDa proteins, and the antigen 85 
complex, which consists of four proteins [71]. These protein 
antigens have been investigated in an effort to find antigens 
that react specifically with sera from animals infected with 
M. paratuberculosis, and not those infected with other 
mycobacterial species. However, these antigens share 
epitopes with M. avium [71].      
  It is believed that young calves are infected by M. para-
tuberculosis via the oral route, through contaminated feces, 
colostrum, or milk. Most infected animals do not develop 
clinical symptoms. Only 10-15% of infected cows develop 
clinical disease, usually after two or more years of infection 
[72]. However, subclinically infected animals may shed 
bacilli intermittently in their feces, spreading infection in 
the herd. Cattle with clinical Johne's disease exhibit decreased 
production, diarrhea, and weight loss [19,71,90]. These 
animals  usually  shed  bacilli  in  their  feces  and  have       
detectable antibodies in their serum. The host response 
to M. paratuberculosis infection results in granulomatous 
lesions in the small intestine. The intestinal wall subsequently 
undergoes progressive thickening, which is caused by 
hypoproteinemia and edema due to decreased intra-
vascular osmotic pressure [19]. Pathological changes in 
the small intestine result in malabsorption of nutrients and 
weight loss. It is not clear which bacterial factors trigger 
multiplication of M. paratuberculosis, or which host re-
sponses control M. paratuberculosis infection [14,18,21, 
22,71,83,94].    2    Seng-Ryong Woo et al.
Entry of M. paratuberculosis into mononuclear 
phagocytes
  After ingestion by young calves, it is thought that the 
bacilli enter intestinal tissue through M cells in the Peyer's 
patches of the small intestine [67]. M. paratuberculosis 
expresses fibronectin attachment proteins (FAPs) [77]. 
Fibronectin bound to these receptors can, in turn, bind to 
integrins on M cells and mediate the uptake of M. para-
tuberculosis [78,79,95]. After crossing the intestinal 
epithelial layer, subepithelial macrophages phagocytose 
bacilli, presumably using several different surface receptors. 
  Mononuclear phagocytes serve as the intracellular niche 
for  M. paratuberculosis survival and multiplication. 
Macrophages are known to have several receptors that are 
involved in the uptake of mycobacteria [7,73,75,85-87]. 
These receptors include complement receptors (CR1, 
CR3, and CR4), immunoglobulin receptors (FcR), the 
mannose receptor, and scavenger receptors [2,29,30,39, 
92]. Human macrophages exhibit decreased uptake of M. 
avium following the addition of anti-CR3 antibodies [11]. 
Serum opsonization of M. tuberculosis increases the up-
take of bacilli by human monocytes, while blocking CR3 
with specific antibody decreased the uptake of bacilli by 
about 87% [76]. Likewise, the uptake of M. paratuberculosis 
by murine macrophages was inhibited by preincubation 
with anti-CR3 monoclonal antibody [17]. Similarly, 
opsonization of M. paratuberculosis with serum from normal 
adult cows or from cows with clinical paratuberculosis 
enhanced the uptake of bacilli by bovine mononuclear 
phagocytes [43,106,112]. These observations suggest that 
complement opsonization is important to the uptake of M. 
paratuberculosis by bovine mononuclear phagocytes. It 
has also been reported that mononuclear phagocytes can 
synthesize and secrete complement proteins that opsonize 
particles for phagocytosis [62].    
Possible mechanisms of intracellular survival 
or death of M. paratuberculosis 
  It is very important to understand the survival mechanisms 
of M. paratuberculosis in bovine mononuclear phagocytes 
if we are to develop more effective ways to control Johne's 
disease. Because infected animals develop clinical symptoms 
of Johne's disease relatively slowly, infected cows presum-
ably can suppress multiplication of M. paratuberculosis 
and delay or prevent the development of Johne's disease. 
  Different routes of entry can alter the intracellular fate of 
ingested bacilli [6,7,23,28,45]. For example, complement 
receptor CR1-mediated uptake of particles does not 
stimulate the production of superoxide anion [23,45]. 
Mannose receptor-mediated uptake of pathogenic or 
nonpathogenic mycobacteria does not activate NADPH 
oxidase in human macrophages [7], and selective receptor 
blockade did not alter the intracellular survival of M. tuber-
culosis in human macrophages [111]. CR3-mediated binding 
and uptake of M. tuberculosis by macrophages does not 
seem to affect the intracellular fate of bacilli [96]. There 
was no difference in bacterial burden or granulomatous 
response between wild-type and complement component 
C3-deficient mice following M. avium infection [12]. 
Opsonization of M. paratuberculosis with normal serum 
from adult cows, or serum containing specific antibodies 
against M. paratuberculosis, increased the uptake of bacilli 
by bovine mononuclear phagocytes. However, intracellular 
survival of M. paratuberculosis in the bovine mononuclear 
phagocytes was not affected [43].  
  Toll-like receptors (TLR) are pattern-recognition receptors 
that detect microbes or microbial components and initiate 
inflammatory responses [63,93]. Antigen- presenting cells 
(APCs), which include dendritic cells and macrophages, 
express TLR receptors and initiate an immune response, 
and then bind to pathogen-associated molecular patterns 
(PAMPs) of microbes [109]. The 19 kDa lipoprotein of M. 
tuberculosis activates murine and human macrophages 
through TLR2, and this, in turn, activates a signaling path-
way that kills intracellular bacilli [84,91]. This 
TLR2-mediated mycobactericidal effect is dependent on 
the production of nitric oxide in murine macrophages and 
enhanced expression of vitamin D receptor in human 
macrophages [58,91]. Bovine monocytes and macrophages 
express mRNA for TLR2 and TLR4 [105]. TLR ligands 
such as lipopolysaccharide (LPS), Salmonella dublin, and 
Listeria monocytogenes activate bovine mononuclear 
phagocytes and induce the production of reactive oxygen 
intermediates (ROIs) [104]. Although there have been no 
reports of how TLR activation alters the intracellular survival 
of M. paratuberculosis, pretreatment of J774 cells and bovine 
monocytes with LPS and IFN-γ  slightly decreased the 
number of viable intracellular M. paratuberculosis bacteria 
[44,110].
  During the process of phagocytosis by macrophages, the 
NADPH oxidase complex on the plasma membrane produces 
a series of ROIs, including superoxide anion, hydrogen 
peroxide, and hydroxyl radical [27,40,80]. These ROIs 
have been implicated in killing mycobacteria [46,50]. 
However, there have been confilicting reports on the my-
cobactericidal effect of ROIs against M. tuberculosis 
[16,34, 55,56,61]. Mycobacteria have some ability to 
evade being killed by ROIs [41,61]. Bovine macrophages 
produce superoxide anion following stimulation with 
phorbol 12-myristate 13-acetate (PMA), zymosan, or LPS 
[104]. However, bovine monocytes and macrophages do 
not stimulate much ROI production after M. paratuberculosis 
infection, and IFN-γ activation of bovine monocytes and 
macrophages did little to increase the release of ROIs 
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which is a possible protective mechanism for intracellular 
bacilli [59]. However, we need more evidence to clarify the 
role of ROIs on the intracellular fate of M. para-
tuberculosis in bovine mononuclear phagocytes.
  Nitric oxide and other reactive nitrogen intermediates 
(RNIs) are known to be major mycobactericidal molecules, 
especially in mice [15,16,32]. After activation with IFN-γ 
and TNF-α, murine macrophages produce significantly 
increased amounts of RNI [60]. Mycobacteria have the 
ability to inhibit recruitment of nitric oxide synthase to my-
cobacteria-containing phagosomes [65]. IFN-γ activation of 
bovine macrophages did not result in increased nitric oxide 
production, whereas IFN-γ-activated murine macrophages 
produced significant amounts of nitric oxide (45-83 µM) at 
72 and 96 h after treatment [3]. Bovine macrophages can 
produce increased nitric oxide in response to other stimuli. 
LPS, Listeria monocytogenes, and Salmonella dublin all 
enhanced the production of nitric oxide (20 to 70 µM) by 
bovine macrophages [3,104]. In contrast, M. para-
tuberculosis-infected bovine macrophages and monocytes 
produced small amounts of nitric oxide (2-3 µM), and IFN-γ 
treatment increased nitric oxide production only to 6-8 µM 
[103]. Stimulation of monocytes with IFN-γ or IFN-γ and 
LPS increased the production of nitric oxide, but the 
amount produced was inadequate to kill intracellular M. 
paratuberculosis [110]. In the granulomatous lesions of 
bovine Johne's disease, the immunoreactivity of inducible 
nitric oxide synthase (iNOS) is weak and localized at or 
near the intestinal crypts [42]. Chemically-generated nitric 
oxide kills extracellular M. paratuberculosis, but bovine 
mononuclear phagocytes do not produce enough nitric oxide 
to kill intracellular M. paratuberculosis [110]. Although 
the inhibition of nitric oxide production resulting from the 
addition of N
G- monomethyl-L-arginine (NMMA) increases 
the intracellular survival of M. tuberculosis in IFN-γ
-pretreated murine macrophages [4], NMMA treatment 
does not promote intracellular survival of M. para-
tuberculosis in bovine monocytes [109]. These data suggest 
that nitric oxide might not be a major mycobactericidal 
mechanism with which to control M. paratuberculosis in 
infected cattle.
    One of the potential microbicidal mechanisms of 
phagocytes is phagosome-lysosome fusion [24,25,98]. 
The lysosomal vacuoles contain potent hydrolytic enzymes 
that kill and degrade ingested microbes [8]. These enzymes 
require an acidic environment for their optimal activity. 
This acidic condition is maintained by a membrane 
ATP-dependent proton pump, the vacuolar H+-ATPase 
[64]. Mycobacterial phagosomes inhibit the recruitment of 
vacuolar H+- ATPase and phagosomal acidification [88]. 
Phagosomal maturation is also inhibited by retention of the 
small GTP- binding protein, Rab5, and by reduced recruitment 
of early endosomal autoantigen 1 (EEA1) to mycobacterial 
phagosomes [36,99]. M. tuberculosis LAM inhibits phagosome 
maturation [37,38,97]. Live M. paratuberculosis cells inhibit 
phagosome- lysosome fusion and phagosomal acidification 
in the J774 murine macrophage cell line, but killed M. para-
tuberculosis cells do not have this effect [51]. Similar results 
were seen in bovine mononuclear phagocytes, in which 
killed  M. paratuberculosis cells were associated with 
greater phagosome-lysosome fusion than live M. para-
tuberculosis cells [107]. Pretreatment with IFN-γ and LPS 
enhanced phagosome-lysosome fusion in murine macro-
phages infected with M. avium or M. bovis BCG [74,100]. 
Treatment of M. paratuberculosis-infected J774 cells with 
IFN-γ and LPS also enhanced phagosome-lysosome fusion 
and the killing of intracellular bacilli [44]. However, the effect 
of IFN-γ and LPS treatment on the maturation of phagosomes 
containing M. paratuberculosis in bovine mononuclear 
phagocytes is unknown. There have been few investigations 
of the molecular mechanisms of phagosomal maturation 
and of the mycobacterial molecules that inhibit phagosome 
maturation in bovine mononuclear phagocytes.
  After infection with M. paratuberculosis, bovine monocytes 
produce TNF-α [1]. Although gene expression of TNF-α 
was identified in ileal tissues of cattle infected with M. para-
tuberculosis, no difference was seen between uninfected 
and infected cattle [57]. TNF-α  treatment  of  murine      
macrophages infected with M. paratuberculosis resulted in 
either enhanced or decreased viability of intracellular bacilli, 
depending on the TNF-α concentrations and the lengths of 
incubation [82]. No report has yet been published on the ef-
fect of TNF-α on intracellular survival of M. paratuberculosis 
in bovine mononuclear phagocytes. 
  Although M. avium is antigenically and genetically very 
similar to M. paratuberculosis, it is generally considered to 
be relatively nonpathogenic in cattle. Bovine macrophages 
expressed greater amounts of IL-10 mRNA following infection 
with M. paratuberculosis than with M. avium [103]. IL-10 
is an anti-inflammatory cytokine that  suppresses the activation 
of macrophages [33]. The IL-10 gene is expressed to a 
greater extent in intestinal tissues and lymph nodes from 
cows clinically infected with M. paratuberculosis than in 
subclinically infected or healthy cows [49]. Bovine macrophages 
infected with M. paratuberculosis produce IL-10, and     
neutralization of IL-10 enhances the killing of intracellular 
bacilli [101]. Another report showed greater production of 
IL-10 from peripheral blood mononuclear cells (PBMC) 
isolated from cows with clinical Johne's disease than from 
healthy cows [49]. Addition of IL-10 increased intracellular 
survival of M. paratuberculosis in PBMCs isolated from 
healthy cows [48]. Neutralization of IL-10 also increased 
the production of IFN-γ by bovine peripheral blood mono-
nuclear cells after infection with M. paratuberculosis, and 
enhanced phagosome acidification and apoptosis of bovine 
macrophages [13,101]. However, the general role of IL-10 
in resistance to mycobacterial infection is not clear. IL-10/ 
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infection than did wild-type mice [69]. 
  Apoptosis is a process of programmed cell death that is 
characterized by DNA fragmentation, nuclear chromatin 
condensation, compacting of cellular organelles, and mem-
brane blebbing [35]. It has been suggested that apoptosis of 
mycobacteria-infected macrophages induces the intracellular 
killing of bacilli, but that necrotic macrophage death does 
not induce the killing of mycobacteria [66]. There have 
been reports that apoptotic stimuli like Fas ligand, TNF-α, 
picolinic acid, ATP, and the mycobacterial 19 kDa lipoprotein 
can kill intracellular mycobacteria in mononuclear phagocytes 
[66,70,72,91]. However, it is not clear whether apoptosis 
of infected macrophages is required for intracellular killing 
of mycobacteria, nor is it clear whether stimuli that induce 
intracellular killing of bacilli are distinct from those that 
trigger apoptosis. M. tuberculosis induced 30-50% apopto-
sis of infected human alveolar macrophages at 2 and 4 days 
after infection, and this occurred via a TNF-α-dependent 
mechanism. Interestingly, pathogenic M. tuberculosis 
evades apoptosis of macrophages by inducing the secretion 
of TNF-R2 from infected macrophages that, in turn, is     
dependent on the production of IL-10 [9]. M. para-
tuberculosis induced 18 to 27% apoptosis of infected bovine 
monocytes at 6 and 48 h after infection, with live bacilli 
causing greater apoptosis than heat-killed M. para-
tuberculosis [5]. In that paper, however, the authors did not 
quantify changes in the intracellular survival of M. 
paratuberculosis. Interestingly, M. paratuberculosis caused 
less apoptosis in bovine macrophages than did M. avium 
[102]. More recently, evidence has indicated that the longer 
survival of M. paratuberculosis within bovine monocytes 
in vitro (4 to 8 days) results in morphological changes that 
may reflect reduced differentiation or survival of the infected 
monocytes [107].
    Extracellular ATP can kill intracellular mycobacteria, 
presumably through the activation of purinergic receptors 
on the surface of infected mononuclear phagocytes. ATP is 
released by nonlytic and lytic mechanisms from both resting 
cells, as well as by cells undergoing apoptotic or necrotic 
cell death. ATP released from lymphocytes or mononuclear 
phagocytes in foci of mycobacterial infection might activate 
purinergic receptors on infected mononuclear phagocytes. 
Extracellular ATP is known to be cytotoxic to macrophages, 
and triggers the killing of mycobacteria in murine and      
human macrophages [26,31, 52-54,68]. This response re-
flects increased intracellular calcium and phospholipase D 
(PLD) activity following ATP activation of P2X7 receptors. 
This subsequently results in increased phagosome-lysosome 
fusion of mycobacterium-containing phagosomes [52,53]. 
It is not clear whether macrophage cytotoxicity is required 
for the mycobactericidal effect of ATP to occur. Bovine 
macrophages express mRNA for the P2X7 receptor, and 
the addition of ATP to bovine macrophages infected with 
M. bovis BCG induced the killing of intracellular bacilli 
[81]. Elimination of extracellular ATP by the addition of 
apyrase increased the survival of M. paratuberculosis-infected 
bovine monocytes, but unexpectedly reduced the survival 
of bacilli. Similarly, the addition of ATP or benzyl-ATP    
reduced the survival of M. paratuberculosis-infected mon-
ocytes, but not the survival of the bacilli themselves [108]. 
Thus, M. paratuberculosis may differ from other mycobacterial 
species in terms of how the presence of ATP affects the  
intracellular survival of bacilli within bovine mononuclear 
phagocytes.           
  In this review, we have described possible intracellular 
survival mechanisms of M. paratuberculosis in infected 
macrophages, mainly in comparison to M. tuberculosis and 
M. avium. M. paratuberculosis seemed to have shared 
strategies with other closely-related mycobacteria for 
intracellular survival, but it also has unique mechanisms. It 
is important to clarify the intracellular survival tactics of 
M. paratuberculosis in order to understand the pathogenesis 
of Johne's disease and develop means by which to prevent 
this disease. However, it is difficult to investigate the survival 
mechanisms of M. paratuberculosis in infected macrophages 
because of the long incubation period required to count 
visible colonies in media and the limited availability of bovine 
reagents to use for this purpose. With the development of 
new technologies and vigorous efforts, these survival 
mechanisms will be better elucidated in the future, and will 
allow us to understand the pathogenesis of this, one of the 
most challenging bacteria to study.
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